CN118105621A - Control method and device for portable nerve regulating equipment and computer storage medium - Google Patents
Control method and device for portable nerve regulating equipment and computer storage medium Download PDFInfo
- Publication number
- CN118105621A CN118105621A CN202410082400.5A CN202410082400A CN118105621A CN 118105621 A CN118105621 A CN 118105621A CN 202410082400 A CN202410082400 A CN 202410082400A CN 118105621 A CN118105621 A CN 118105621A
- Authority
- CN
- China
- Prior art keywords
- mobile terminal
- portable
- control
- control method
- portable nerve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000005036 nerve Anatomy 0.000 title claims abstract description 115
- 238000000034 method Methods 0.000 title claims abstract description 57
- 230000001105 regulatory effect Effects 0.000 title claims description 24
- 230000000638 stimulation Effects 0.000 claims abstract description 26
- 230000004007 neuromodulation Effects 0.000 claims abstract description 22
- 230000006870 function Effects 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 9
- 206010001497 Agitation Diseases 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000001537 neural effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001054 cortical effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000003710 cerebral cortex Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000337 motor cortex Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 210000000877 corpus callosum Anatomy 0.000 description 1
- 230000002594 corticospinal effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000003291 dopaminomimetic effect Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 230000001121 heart beat frequency Effects 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 210000001926 inhibitory interneuron Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000010291 membrane polarization Effects 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000008062 neuronal firing Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036390 resting membrane potential Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000002295 serotoninergic effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 230000003956 synaptic plasticity Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K7/00—Methods or arrangements for sensing record carriers, e.g. for reading patterns
- G06K7/10—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation
- G06K7/14—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation using light without selection of wavelength, e.g. sensing reflected white light
- G06K7/1404—Methods for optical code recognition
- G06K7/1408—Methods for optical code recognition the method being specifically adapted for the type of code
- G06K7/1417—2D bar codes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Theoretical Computer Science (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Artificial Intelligence (AREA)
- General Physics & Mathematics (AREA)
- Evolutionary Computation (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Toxicology (AREA)
- Electromagnetism (AREA)
- Software Systems (AREA)
- Mathematical Physics (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Pulmonology (AREA)
- Data Mining & Analysis (AREA)
- Computational Linguistics (AREA)
- Telephone Function (AREA)
Abstract
The application provides a control method, a device and a computer storage medium of a portable nerve regulation device, wherein the control method is applied to a control system, the control system comprises the portable nerve regulation device and a mobile terminal, and the control method comprises the following steps: the mobile terminal is connected with the portable nerve adjusting device; the mobile terminal acquires and displays a first control interface of the portable nerve adjusting device; responding to a first control instruction input by a user on the first control interface, and sending the first control instruction to the portable nerve adjusting equipment by the mobile terminal; the portable neuromodulation device outputs a stimulation current according to the first control instruction. Through the mode, the control function improves the control flexibility of the portable nerve adjusting device.
Description
Technical Field
The present application relates to the field of system control technologies, and in particular, to a method and apparatus for controlling a portable neuromodulation device, and a computer storage medium.
Background
Constructing distributed clusters based on cloud-native schemes has become the current mainstream scheme, and clusters made up of thousands of nodes are also put into use in many fields, with billions of containers running per week in Google. In the field of big data, the large data cluster constructed by using cloud protogenesis is larger and larger, the configuration of big data components is a complex work all the time, if the parameter configuration of a certain service needs to be modified, a user needs to modify configuration files on all nodes one by one, when the cluster size reaches hundreds of nodes or thousands of nodes, the maintenance by manpower is very difficult, and the correctness of the parameter configuration of all the nodes is difficult to ensure.
Disclosure of Invention
In order to solve the technical problems, the application provides a control method of a portable nerve modulation device, a control system of the portable nerve modulation device and a computer storage medium.
In order to solve the technical problem, the application provides a control method of a portable nerve modulation device, the control method is applied to a control system, the control system comprises the portable nerve modulation device and a mobile terminal, and the control method comprises the following steps: the mobile terminal is connected with the portable nerve adjusting device; the mobile terminal acquires and displays a first control interface of the portable nerve adjusting device; responding to a first control instruction input by a user on the first control interface, and sending the first control instruction to the portable nerve adjusting equipment by the mobile terminal; the portable neuromodulation device outputs a stimulation current according to the first control instruction.
Wherein, remove the end and connect portable nerve adjusting device includes: the portable nerve adjusting device is connected with the two-dimensional code in a display mode; the mobile terminal scans the connection two-dimensional code to acquire connection information of the portable nerve adjusting device; the mobile terminal connects the portable neuromodulation device based on the connection information.
Wherein the control method further comprises: the portable nerve regulating device displays and configures a two-dimensional code; the mobile terminal scans the configuration two-dimensional code and displays a configuration interface of the portable nerve adjusting device; responding to configuration information input by a user at the configuration interface, and transmitting the configuration information to the portable nerve adjusting equipment by the mobile terminal; the portable neuromodulation device resets the device configuration in accordance with the configuration information.
Wherein, the mobile terminal is preset with a configuration template in advance; after the configuration interface of the portable nerve modulation device is displayed, the control method further includes: and responding to a template configuration instruction, and enabling the mobile terminal to cover configuration information of the portable nerve adjusting device in the configuration interface with configuration information in the configuration template.
Wherein, the control method further comprises: the portable nerve regulating device collects vital signs of a user and sends the vital signs to the mobile terminal; the mobile terminal displays a vital sign interface on the first control interface in real time; responding to the situation that the vital sign is higher than a preset early warning threshold, the mobile terminal sends a temporary suspension instruction to the portable nerve adjusting device and outputs an early warning signal to a user; the first control interface includes one or more of a control mode function, a current control function, a time control function, a timing control function, a switch control function.
Wherein, the control method further comprises: the mobile terminal displays a portable nerve modulation device list on the first control interface; the mobile terminal obtains the real-time use state of each portable nerve regulating device on the portable nerve regulating device list and displays the real-time use state on the portable nerve regulating device list; and the mobile terminal outputs a use suggestion according to the user requirement and the real-time use state.
Wherein, the control system also comprises an intelligent medical cloud platform; the control method further comprises the following steps: the mobile terminal obtains the working state of the portable nerve adjusting device and uploads user information to the intelligent medical cloud platform; the intelligent medical cloud platform extracts a user file according to the user information and transmits the user file to the mobile terminal; and the mobile terminal adjusts a first control instruction according to the working state and the user file.
Wherein, a second control interface is arranged on the portable nerve adjusting device; the control method further includes: and responding to a second control instruction input by a user at the second control interface, and generating a stimulation current by the portable nerve regulating device according to the second control instruction.
In order to solve the technical problem, the application provides a control system of a portable nerve modulation device, which comprises a memory and a processor coupled with the memory; the memory is used for storing program data, and the processor is used for executing the program data to realize the control method.
In order to solve the above technical problem, the present application proposes a computer storage medium for storing program data, which when executed by a computer, is configured to implement the above control method.
Compared with the prior art, the application has the beneficial effects that: the mobile terminal is connected with the portable nerve adjusting device; the mobile terminal acquires and displays a first control interface of the portable nerve adjusting device; responding to a first control instruction input by a user on the first control interface, and sending the first control instruction to the portable nerve adjusting equipment by the mobile terminal; the portable neuromodulation device outputs a stimulation current according to the first control instruction. Through the mode, the control function improves the control flexibility of the portable nerve adjusting device.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for the description of the embodiments will be briefly described below, and it is apparent that the drawings in the following description are only some embodiments of the present application, and other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
Wherein:
Fig. 1 is a schematic flow chart of a first embodiment of a control method of a portable nerve modulation device provided by the present application;
fig. 2 is a schematic flow chart of a second embodiment of a control method of a portable nerve modulation device according to the present application;
FIG. 3 is a flow chart of a third embodiment of a method of controlling a portable neuromodulation device provided by the present application;
FIG. 4 is a schematic diagram of a control system of a portable neuromodulation device in accordance with one embodiment of the present application;
fig. 5 is a schematic structural diagram of an embodiment of a computer storage medium provided by the present application.
Detailed Description
The following description of the embodiments of the present application will be made clearly and fully with reference to the accompanying drawings, in which it is evident that the embodiments described are only some, but not all embodiments of the application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
The terms "first," "second," "third," "fourth" and the like in the description and in the claims and in the above drawings, if any, are used for distinguishing between similar objects and not necessarily for describing a particular sequential or chronological order. It is to be understood that the data so used may be interchanged where appropriate such that the embodiments of the application described herein may be implemented, for example, in sequences other than those illustrated or otherwise described herein. Furthermore, the terms "comprises," "comprising," and "having," and any variations thereof, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
Referring specifically to fig. 1, fig. 1 is a flowchart illustrating a control method of a portable nerve modulation device according to a first embodiment of the present application.
The control method of the portable nerve regulating device is applied to a control system, and the control system comprises the portable nerve regulating device and a mobile terminal.
As shown in fig. 1, the specific steps are as follows:
Step S11: the mobile terminal is connected with the portable nerve adjusting device.
The portable nerve regulating device is a wearable device, and can detect data and regulate current by connecting with the Internet and combining with software application and an operating system to execute a biosensing function.
In particular, portable neuromodulation devices rely on transcranial direct current stimulation (TRANSCRANIAL DIRECT Current Stimulation, abbreviated as "tDCS"). The aim is to stimulate the frontal lobe, whose activity is related to depression, sending a current through the electrodes to a specific area of the brain, which can assist in interrupting and restoring the neural signals associated with depression, thus alleviating the symptoms.
TDCS is a non-invasive technique that uses weak currents (1-2 mA) to regulate cerebral cortical neural cell activity. The brain cortex is acted on with a weak polarized direct current by two electrodes placed on the scalp. tDCS consists of two surface electrode plates, cathode, which inhibits the cerebral cortex and anode, which excites the cerebral cortex. Neurophysiologic studies have shown that tDCS modulate neurotransmitters such as: glutamate, r-aminobutyric acid, dopamine, serotonin, and cholinergic effects.
The application of the tDCS technology in the nerve rehabilitation field is gradually promoted, and researches show that the tDCS has different treatment effects on limb movement disorder, cognitive disorder, aphasia, depression, senile dementia, parkinsonism and spinal cord neural network excitability change after cerebral apoplexy, and is a noninvasive brain stimulation technology with a very development prospect in the nerve rehabilitation field. In addition, the studies prove that the effect of the conventional rehabilitation can be improved by jointly using the tDCS and the rehabilitation. In recent years, studies have also found that tDCS has a certain therapeutic effect on fibromyalgia syndrome, neuralgia, low back pain, and the like. tDCS is the use of different polarity currents (anodic or cathodic) for the purpose of increasing or decreasing neuronal activity, acting as neuromodulators.
TDCS consists of two surface electrodes, anode and cathode, and the output of stimulation type is set by control software to act weak polarized direct current on cerebral cortex. Unlike other non-invasive brain stimulation techniques such as transcranial electrical stimulation and transcranial magnetic stimulation, tDCS does not cause neuronal firing by suprathreshold stimulation, but rather functions by modulating the activity of the neural network. At the neuronal level, the basic mechanism by which tDCS regulates cortical excitability is to cause hyperpolarization or a change in depolarization of the resting membrane potential depending on the polarity of the stimulus. Anodal stimulation generally increases the excitability of the cortex, while cathodal stimulation decreases the excitability of the cortex. Polarization of the membrane is the primary mechanism of action immediately after tDCS stimulation.
However, in addition to immediate effects, tDCS also has a post-stimulation effect, if the stimulation time is long enough, the change in cortical excitability can last up to 1h after the stimulation is over. Therefore, its mechanism of action cannot be explained solely by polarization of neuronal membrane potential. Further studies have shown that tDCS, in addition to altering the polarity of the membrane potential, can also modulate the microenvironment of the synapse, such as altering the activity of NMDA receptors or GABA, thereby acting to modulate synaptic plasticity. the posteffector mechanisms of tDCS are similar to the long-term facilitation of synapses, and animal studies have found that sustained increases in postsynaptic excitatory potential can be observed with anodal stimulation on the motor cortex. Modulation of cortical excitability depends on the level of membrane polarization at tDCS stimulation, whereas post-effects after stimulation are mainly due to synaptic activity within the dermis.
TDCS can also modulate the excitability of the far cortex and subcortical regions. the tDCS anodically stimulates the anterior motor cortex region to affect excitatory changes in the connected distal cortex region. Stimulation of the left hemisphere M1 region not only affects the corticospinal loop involved in the generation of motor evoked potentials, but also regulates the suppression of the corpus callosum in the contralateral hemisphere by inhibitory interneurons.
In the embodiment of the application, the mobile terminal can be mobile communication equipment such as a mobile phone, a tablet and the like. The PC end can also be connected through a network.
In this embodiment, the mobile terminal may be connected to the portable nerve modulation device through two-dimensional code scanning, and in other embodiments of the present application, the mobile terminal may also be connected through various information sensors and radio frequency identification technologies, and when the mobile terminal approaches the portable nerve modulation system, the mobile terminal is automatically connected to the portable nerve modulation device.
Further, in an embodiment of the present application, the portable nerve adjusting device may be scanned for the mobile terminal through the process of two-dimensional code connection, specifically, the portable nerve adjusting device displays the connected two-dimensional code; the mobile terminal scans and connects the two-dimensional code, obtain the connection information of the portable nerve regulating equipment; the mobile terminal is connected with the portable nerve adjusting device based on the connection information.
In another embodiment of the present application, the mobile terminal may be scanned by a portable nerve adjusting device, and in particular, the portable nerve adjusting system is provided with a camera, and the portable nerve adjusting device scans the two-dimensional code displayed on the mobile terminal, so that the mobile terminal is connected with the portable nerve adjusting device.
It should be noted that, the mobile terminal is installed with a corresponding application program, the mobile terminal can scan the nerve adjusting device through the scanning function in the application program, the mobile terminal can also scan the nerve adjusting device through the self-contained scanning function, after scanning the portable nerve adjusting system, the mobile terminal automatically jumps to the interface of the application program, and the application program can also display the two-dimension code, so that the portable nerve adjusting device is connected with the mobile terminal.
Step S12: the mobile terminal acquires and displays a first control interface of the portable nerve modulation device.
Specifically, after the mobile terminal and the portable nerve modulation device are successfully connected, the mobile terminal acquires and displays a first control interface of the portable nerve modulation device.
If the connection is unsuccessful, prompting reasons of unsuccessful connection in a display interface of the mobile terminal, including but not limited to equipment failure, network failure and the like.
In other embodiments of the present application, the portable neuromodulation device may also include a display screen to display the cause of the connection failure.
In other embodiments of the present application, the portable nerve modulation device may also prompt whether the connection is successful by using different vibration frequencies, so as to avoid that the user directly puts down the mobile terminal after scanning the mobile terminal without receiving a connection failure instruction.
Further, the portable nerve modulation device also includes a display interface, and the second control interface is the display interface of the portable nerve modulation device, and the portable nerve modulation device generates a stimulation current according to the second control instruction in response to the second control instruction input by the user at the second control interface. I.e. the worn portable nerve modulation device can be operated and controlled by other people.
Step S13: and responding to a first control instruction input by a user on the first control interface, and transmitting the first control instruction to the portable nerve adjusting device by the mobile terminal.
In an embodiment of the application, the portable nerve modulation device displays a configuration two-dimensional code; the mobile terminal scans and configures the two-dimensional code and displays a configuration interface of the portable nerve adjusting equipment; responding to configuration information input by a user on a configuration interface, and transmitting the configuration information to the portable nerve adjusting equipment by the mobile terminal; the portable neuromodulation device resets the device configuration according to the configuration information.
The configuration information includes, but is not limited to, power on/off, parameters of the portable nerve modulation device, vibration frequency, etc.
In an embodiment of the present application, after a configuration template is preset in advance on a mobile terminal and a configuration interface of a portable nerve adjusting device is displayed, the mobile terminal responds to a template configuration instruction, and the configuration information in the configuration template covers the configuration information of the portable nerve adjusting device in the configuration interface.
In this way, the configuration of the portable neuromodulation device is adjusted.
Step S14: the portable neuromodulation device outputs the stimulation current according to the first control command.
Specifically, the portable nerve modulation device outputs a stimulation current according to the first control instruction, and generates current stimulation to the target site.
Further, the present application also proposes an embodiment, and in particular, referring to fig. 2, fig. 2 is a schematic flow chart of a second embodiment of a control method of a portable nerve modulation device according to the present application.
As shown in fig. 2, the specific steps are as follows:
Step S21: the portable nerve regulating device collects vital signs of a user and sends the vital signs to the mobile terminal.
Specifically, the portable neuromodulation device collects vital signs of the user and transmits the vital signs to the mobile terminal. Vital signs include, but are not limited to, the heart beat frequency, brain wave frequency, body temperature of the user, and fluctuations in the above information.
Step S22: the mobile terminal displays the vital sign interface in real time on the first control interface.
Wherein the first control interface includes one or more of a control mode function, a current control function, a time control function, a timing control function, a switch control function.
Specifically, the mobile terminal displays the vital sign interface on the first control interface in real time, and the vital sign interface can be displayed in a list mode or in a data diagram mode.
Step S23: and responding to the vital sign being higher than a preset early warning threshold, the mobile terminal sends a temporary suspension instruction to the portable nerve adjusting equipment and outputs an early warning signal to a user.
Specifically, when the vital sign is higher than a preset early warning threshold, the mobile terminal sends a temporary suspension instruction to the portable nerve regulating device, and outputs an early warning signal to a user, so that the portable nerve regulating device is improved.
In other embodiments of the present application, the user is further supported to set a modification threshold, and when the user modified threshold exceeds the limit that the human body can withstand, the mobile terminal prohibits the modification of the numerical value to the set threshold and automatically fills in the recommended value.
Further, in an embodiment of the present application, the mobile terminal displays a list of portable neuromodulation devices on the first control interface; the mobile terminal obtains the real-time use state of each portable nerve regulating device on the portable nerve regulating device list and displays the real-time use state on the portable nerve regulating device list; the mobile terminal outputs the use suggestion according to the user requirement and the real-time use state.
The use advice may be output based on personal information filled in by the user or by historical use of the user.
In an embodiment of the present application, the control system further includes an intelligent medical cloud platform, and referring to fig. 3, fig. 3 is a schematic flow chart of a third embodiment of the control method of the portable nerve modulation device provided by the present application.
Step S31: the mobile terminal obtains the working state of the portable nerve adjusting device and uploads the user information to the intelligent medical cloud platform.
The mobile terminal obtains the working state of the portable nerve adjusting device and uploads the user information to the intelligent medical cloud platform.
Step S32: and the intelligent medical cloud platform extracts the user file according to the user information and transmits the user file to the mobile terminal.
Specifically, the intelligent medical cloud platform can extract key information of the user file, and the information extraction mode includes, but is not limited to, using an intelligent semantic model, extracting historical medical information of the user, inquiry records and the like.
Step S33: the mobile terminal adjusts the first control instruction according to the working state and the user file.
The mobile terminal adjusts the first control instruction according to the working state of the shortcut nerve adjusting device and the user file. Through the mode, intelligent regulation efficiency of the portable nerve regulation equipment is improved.
It will be appreciated by those skilled in the art that in the above-described method of the specific embodiments, the written order of steps is not meant to imply a strict order of execution but rather should be construed according to the function and possibly inherent logic of the steps.
In order to realize the control method of the portable nerve modulation device, the application further provides a control system of the portable nerve modulation device, and particularly referring to fig. 4, fig. 4 is a schematic structural diagram of an embodiment of the control system of the portable nerve modulation device.
The control system 400 of the portable nerve modulation device of the present embodiment includes a processor 41, a memory 42, an input-output device 43, and a bus 44.
The processor 41, the memory 42, and the input/output device 43 are respectively connected to the bus 44, and the memory 42 stores program data, and the processor 41 is configured to execute the program data to implement the control method of the portable nerve modulation device according to the above embodiment.
In an embodiment of the present application, the processor 41 may also be referred to as a CPU (Central Processing Unit ). The processor 41 may be an integrated circuit chip with signal processing capabilities. Processor 41 may also be a general purpose processor, a digital signal processor (DSP, digital Signal Process), an Application Specific Integrated Circuit (ASIC), a field programmable gate array (FPGA, field Programmable GATE ARRAY) or other programmable logic device, discrete gate or transistor logic device, discrete hardware components. The general purpose processor may be a microprocessor or the processor 41 may be any conventional processor or the like.
The present application further provides a computer storage medium, and referring to fig. 5, fig. 5 is a schematic structural diagram of an embodiment of the computer storage medium provided by the present application, in which a computer program 61 is stored in the computer storage medium 600, and the computer program 61 is used to implement the control method of the portable neuromodulation device of the above embodiment when being executed by a processor.
Embodiments of the present application may be stored in a computer readable storage medium when implemented in the form of software functional units and sold or used as a stand alone product. Based on such understanding, the technical solution of the present application may be embodied in essence or a part contributing to the prior art or all or part of the technical solution in the form of a software product stored in a storage medium, including several instructions for causing a computer device (which may be a personal computer, a server, or a network device, etc.) or a processor (processor) to execute all or part of the steps of the method according to the embodiments of the present application. And the aforementioned storage medium includes: a usb disk, a removable hard disk, a Read-Only Memory (ROM), a random access Memory (RAM, random Access Memory), a magnetic disk, or an optical disk, or other various media capable of storing program codes.
The foregoing description is only of embodiments of the present application, and is not intended to limit the scope of the application, and all equivalent structures or equivalent processes using the descriptions and the drawings of the present application or directly or indirectly applied to other related technical fields are included in the scope of the present application.
Claims (10)
1. A control method of a portable neuromodulation device, the control method being applied to a control system comprising the portable neuromodulation device and a mobile terminal, the control method comprising:
the mobile terminal is connected with the portable nerve adjusting device;
the mobile terminal acquires and displays a first control interface of the portable nerve adjusting device;
Responding to a first control instruction input by a user on the first control interface, and sending the first control instruction to the portable nerve adjusting equipment by the mobile terminal;
the portable neuromodulation device outputs a stimulation current according to the first control instruction.
2. The control method according to claim 1, wherein,
The mobile terminal is connected with the portable nerve modulation device, and comprises:
The portable nerve adjusting device is connected with the two-dimensional code in a display mode;
the mobile terminal scans the connection two-dimensional code to acquire connection information of the portable nerve adjusting device;
the mobile terminal connects the portable neuromodulation device based on the connection information.
3. The control method according to claim 2, wherein,
The control method further includes:
The portable nerve regulating device displays and configures a two-dimensional code;
the mobile terminal scans the configuration two-dimensional code and displays a configuration interface of the portable nerve adjusting device;
Responding to configuration information input by a user at the configuration interface, and transmitting the configuration information to the portable nerve adjusting equipment by the mobile terminal;
The portable neuromodulation device resets the device configuration in accordance with the configuration information.
4. The control method according to claim 3, wherein,
The mobile terminal is preset with a configuration template in advance;
after the configuration interface of the portable nerve modulation device is displayed, the control method further includes:
and responding to a template configuration instruction, and enabling the mobile terminal to cover configuration information of the portable nerve adjusting device in the configuration interface with configuration information in the configuration template.
5. The control method according to claim 1, wherein,
The control method further comprises the following steps:
The portable nerve regulating device collects vital signs of a user and sends the vital signs to the mobile terminal;
the mobile terminal displays a vital sign interface on the first control interface in real time;
Responding to the situation that the vital sign is higher than a preset early warning threshold, the mobile terminal sends a temporary suspension instruction to the portable nerve adjusting device and outputs an early warning signal to a user;
the first control interface includes one or more of a control mode function, a current control function, a time control function, a timing control function, a switch control function.
6. The control method according to claim 1, wherein,
The control method further comprises the following steps:
The mobile terminal displays a portable nerve modulation device list on the first control interface;
the mobile terminal obtains the real-time use state of each portable nerve regulating device on the portable nerve regulating device list and displays the real-time use state on the portable nerve regulating device list;
And the mobile terminal outputs a use suggestion according to the user requirement and the real-time use state.
7. The control method according to claim 1, wherein,
The control system also comprises an intelligent medical cloud platform;
The control method further comprises the following steps:
The mobile terminal obtains the working state of the portable nerve adjusting device and uploads user information to the intelligent medical cloud platform;
the intelligent medical cloud platform extracts a user file according to the user information and transmits the user file to the mobile terminal;
And the mobile terminal adjusts a first control instruction according to the working state and the user file.
8. The control method according to claim 1, wherein,
The portable nerve modulation device is provided with a second control interface;
The control method further includes:
and responding to a second control instruction input by a user at the second control interface, and generating a stimulation current by the portable nerve regulating device according to the second control instruction.
9. A control system for a portable neuromodulation device, the control system comprising a memory and a processor coupled to the memory;
wherein the memory is for storing program data and the processor is for executing the program data to implement the control method according to any one of claims 1 to 8.
10. A computer storage medium for storing program data which, when executed by a computer, is adapted to carry out the control method according to any one of claims 1 to 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410082400.5A CN118105621A (en) | 2024-01-19 | 2024-01-19 | Control method and device for portable nerve regulating equipment and computer storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410082400.5A CN118105621A (en) | 2024-01-19 | 2024-01-19 | Control method and device for portable nerve regulating equipment and computer storage medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118105621A true CN118105621A (en) | 2024-05-31 |
Family
ID=91217227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410082400.5A Pending CN118105621A (en) | 2024-01-19 | 2024-01-19 | Control method and device for portable nerve regulating equipment and computer storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118105621A (en) |
-
2024
- 2024-01-19 CN CN202410082400.5A patent/CN118105621A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8914123B2 (en) | Apparatus for electro-inhibition of facial muscles | |
| Shah et al. | Optimization of electrical stimulation for a high-fidelity artificial retina | |
| US20150352364A1 (en) | Neuroprosthetic stimulation | |
| CN115054828B (en) | Pulse generator, medical system, and computer-readable storage medium | |
| BRPI0709844A2 (en) | Cranial nerve micrograde electrical stimulation for the treatment of medical conditions | |
| JP2016530017A (en) | System and method for non-invasive neural stimulation | |
| CN116510179A (en) | Stimulator control method and system based on multi-balance stimulation strategy | |
| JP2020520778A (en) | Crossed short pulse electrical stimulation of the brain | |
| CN116617564A (en) | Stimulator control method and system | |
| WO2019033213A1 (en) | Contingent stimulation for augmentation of memory | |
| JP2019058666A (en) | Stimulating apparatus and method therefor | |
| CN116549849A (en) | Method and system for detecting impedance state of stimulator | |
| WO2016134273A1 (en) | Topical nerve stimulator and sensor for pain management | |
| EP3965874A1 (en) | Method and apparatus for multimodal or multiplexed electrical modulation of pain using composite electromagnetic fields | |
| CN118105621A (en) | Control method and device for portable nerve regulating equipment and computer storage medium | |
| CN118634429A (en) | Pulse generators and electrical stimulation equipment | |
| CN221470740U (en) | Transcranial electrical stimulation system | |
| CN116421887A (en) | Soft start control method and system of stimulator | |
| CN112370659B (en) | Implementation method of head stimulation training device based on machine learning | |
| CN117357787A (en) | Transcranial electrical stimulation system | |
| McDermott et al. | Feedback control for deep brain stimulation for motor disorders | |
| Lotlikar et al. | Partitioned temporal dithering for efficient epiretinal electrical stimulation | |
| US20200297992A1 (en) | Primary Dysmenorrhea Pain Reduction | |
| JP2019510568A (en) | Brain tissue stimulation method, apparatus and computer program | |
| Rubinstein et al. | The neurophysiological effects of simulated auditory prosthesis stimulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |